Although rare, primary systemic vasculitis in children is associated with significant mortality and morbidity when not properly treated. Optimal management of the group of multiorgan inflammatory conditions is hampered by the lack of evidence-based therapies. The shortage of data has been attributed in part to the absence of a standardized outcome measure for use in clinical trials, according to Dr. Pavla Dolezalova.
PREVIEW